SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer to Drive Global Expansion

SS Innovations International, a developer of innovative surgical robotic technologies focused on making robotic surgery affordable and accessible globally, has appointed Naveen Kumar Amar as the company's Chief Financial Officer effective September 24, 2025. The appointment marks a strategic move to bolster the company's financial leadership as it expands the global presence of its SSi Mantra surgical robotic system.

Mr. Amar assumes the CFO role on a permanent basis from Dr. Vishwa Srivastava, who served as Interim Chief Financial Officer since July 2025 and will continue as Chief Executive Officer for the Asia Pacific region. The transition comes at a critical juncture for SS Innovations as the company seeks to democratize access to advanced surgical robotic care worldwide.

With more than 25 years of global finance leadership experience spanning diverse industries and geographies, Mr. Amar brings substantial expertise to the position. His background includes financial accounting and reporting, planning and analysis, budgeting, forecasting, corporate finance, treasury operations, governance, internal controls, and proficiency in both U.S. and Indian GAAP. His recognition as one of India's top financial executives by publications including Forbes India magazine, Forbes Asia magazine, CFO India Forum, and Chartered Institute of Management Accountants, London underscores his qualifications for the role.

Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, emphasized the significance of the appointment, stating that Amar brings a strong track record of building best-in-class finance operations, effective cross-functional teams, and successful businesses across diverse industries and geographies. The leadership addition comes as the company expands the global presence of its advanced, cost-efficient SSi Mantra surgical robotic system available through their website at https://ssinnovations.com.

Mr. Amar expressed honor in joining SS Innovations during what he described as an exciting stage in the company's journey to democratize access to advanced surgical robotic care. He noted his commitment to helping the team drive growth and deliver sustainable long-term shareholder value. His most recent experience includes providing virtual CFO services to clients in the United States, Canada, and the United Kingdom.

The appointment carries significant implications for the medical technology industry, particularly in the surgical robotics sector where cost barriers have limited widespread adoption. SS Innovations' focus on affordability and accessibility through products like the SSi Mantra system represents a potential market disruptor. The SSi Mantra surgical robotic system features modular, multi-arm technology with advanced capabilities including 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, large 3D 4K monitor, and support for over 40 different types of robotic endo-surgical instruments.

Mr. Amar's extensive background includes previous leadership positions as Head of Finance & Commercial for SpiceXpress, Global CFO for Munch Ado India Private Ltd., Senior Vice President of Finance & Compliance and Company Secretary for MSD Wellcome Trust Hilleman Laboratories Private Ltd., and financial leadership roles at EDirect Proprietary Ltd. and GE India. His educational credentials include a Bachelor of Commerce degree from the University of Delhi, a post graduate diploma in Business Management from All India Management Association's Centre of Management Education, and professional designations as Chartered Accountant from the Institute of Chartered Accountants of India and Company Secretary from the Institute of Company Secretaries of India.

The strategic appointment signals SS Innovations' commitment to strengthening its financial governance and operational excellence as it scales its global operations. With the SSi Mantra system already clinically validated in India through more than 100 different surgical procedures, the company's expansion efforts under strengthened financial leadership could potentially increase competition in the surgical robotics market and improve patient access to advanced surgical care worldwide.